Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Edematous Fibrosclerotic Panniculopathy (EFP)”

12 trials

Showing 12 of 12 results

Large-scale testing (Phase 3)Study completedNCT03428750
What this trial is testing

Effectiveness and Safety of EN3835 in the Treatment of EFP (Cellulite) in Women

Who this might be right for
Edematous Fibrosclerotic Panniculopathy (Cellulite)
Endo USA Inc., a Keenova Therapeutics Company 423
Testing effectiveness (Phase 2)Study completedNCT05836779
What this trial is testing

Evaluate the Efficacy and Safety of CBL-514 in Participants With EFP; Cellulite (Stage 2)

Who this might be right for
Cellulite
Caliway Biopharmaceuticals Co., Ltd. 23
Testing effectiveness (Phase 2)Study completedNCT03632993
What this trial is testing

Injection Techniques of Collagenase Clostridium Histolyticum (CCH) for the Treatment of EFP (Cellulite)

Who this might be right for
Edematous Skin
Endo USA Inc., a Keenova Therapeutics Company 64
Not applicableStudy completedNCT03893890
What this trial is testing

Durability and Safety of EN3835 in the Treatment of EFP (Cellulite) in Women

Who this might be right for
Edematous Fibrosclerotic Panniculopathy
Endo USA Inc., a Keenova Therapeutics Company 8
Testing effectiveness (Phase 2)Study completedNCT03329989
What this trial is testing

Safety and Effectiveness of EN3835 in the Treatment of EFP in Women

Who this might be right for
Edematous Fibrosclerotic PanniculopathyCellulite
Endo USA Inc., a Keenova Therapeutics Company 158
Early research (Phase 1)Study completedNCT03675685
What this trial is testing

Safety and Pharmacokinetics of a Single Dose of CCH (3.36 mg) in Subjects With EFP

Who this might be right for
Edematous Fibrosclerotic Panniculopathy
Endo USA Inc., a Keenova Therapeutics Company 12
Testing effectiveness (Phase 2)Study completedNCT05632926
What this trial is testing

Evaluate the Efficacy and Safety of CBL-514 in Participants With EFP; Cellulite (Stage 1)

Who this might be right for
Cellulite
Caliway Biopharmaceuticals Co., Ltd. 12
Testing effectiveness (Phase 2)Ended earlyNCT04209530
What this trial is testing

Impact of CCH Treatment of Buttock and Thigh Cellulite in Adult Women

Who this might be right for
CelluliteEdematous Fibrosclerotic Panniculopathy (EFP)
Endo USA Inc., a Keenova Therapeutics Company 7
Post-approval studies (Phase 4)Study completedNCT04677712
What this trial is testing

Effects of Mitigation Treatments on Bruising of CCH-aaes Treatment of Buttock Cellulite

Who this might be right for
Edematous Fibrosclerotic Panniculopathy (EFP)Cellulite
Endo USA Inc., a Keenova Therapeutics Company 48
Testing effectiveness (Phase 2)Study completedNCT01987986
What this trial is testing

A Phase 2, Randomized, Double-blind, Placebo Controlled Dose Ranging Study of Repeat Doses of AA4500 for the Treatment of Edematous Fibrosclerotic Panniculopathy

Who this might be right for
Edematous Fibrosclerotic Panniculopathy (EFP)
Endo USA Inc., a Keenova Therapeutics Company 150
Not applicableStudy completedNCT04381117
What this trial is testing

Long-term Durability Study of Collagenase Clostridium Histolyticum (CCH)

Who this might be right for
Edematous Fibrosclerotic Panniculopathy
Endo USA Inc., a Keenova Therapeutics Company 7
Large-scale testing (Phase 3)Study completedNCT04170296
What this trial is testing

Real World CCH Study in Adult Females With Cellulite

Who this might be right for
Edematous Fibrosclerotic Panniculopathy (EFP)Cellulite
Endo USA Inc., a Keenova Therapeutics Company 153

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation